These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22777336)

  • 61. Fracture prediction from repeat BMD measurements in clinical practice.
    Leslie WD; Brennan-Olsen SL; Morin SN; Lix LM
    Osteoporos Int; 2016 Jan; 27(1):203-10. PubMed ID: 26243362
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.
    Bouxsein ML; Eastell R; Lui LY; Wu LA; de Papp AE; Grauer A; Marin F; Cauley JA; Bauer DC; Black DM;
    J Bone Miner Res; 2019 Apr; 34(4):632-642. PubMed ID: 30674078
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proton pump inhibitors therapy and risk of bone diseases: An update meta-analysis.
    Liu J; Li X; Fan L; Yang J; Wang J; Sun J; Wang Z
    Life Sci; 2019 Feb; 218():213-223. PubMed ID: 30605646
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study.
    Richards JB; Joseph L; Schwartzman K; Kreiger N; Tenenhouse A; Goltzman D;
    Osteoporos Int; 2006; 17(9):1410-9. PubMed ID: 16791706
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
    Shetty S; John B; Mohan S; Paul TV
    Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Changes in vascular calcification and bone mineral density in calcium supplement users from the Canadian Multi-center Osteoporosis Study (CaMOS).
    Hulbert M; Turner ME; Hopman WM; Anastassiades T; Adams MA; Holden RM
    Atherosclerosis; 2020 Mar; 296():83-90. PubMed ID: 31859056
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals.
    Maggio M; Lauretani F; Ceda GP; De Vita F; Bondi G; Corsonello A; Cattabiani C; Lattanzio F; Ruggiero C; Nouvenne A; Meschi T; Bandinelli S; Ferrucci L
    Bone; 2013 Dec; 57(2):437-42. PubMed ID: 24076021
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
    Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
    JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use.
    Lyu H; Zhao SS; Yoshida K; Tedeschi SK; Xu C; Nigwekar SU; Leder BZ; Solomon DH
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5611-5620. PubMed ID: 31265071
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Longitudinal study on physical fitness parameters influencing bone mineral density reduction in middle-aged and elderly women: bone mineral density in the lumbar spine, femoral neck, and femur.
    Iida T; Ikeda H; Shiokawa M; Aoi S; Ishizaki F; Harada T; Ono Y
    Hiroshima J Med Sci; 2012 Jun; 61(2):23-8. PubMed ID: 22916509
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
    J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Location of Vertebral Fractures is Associated with Bone Mineral Density and History of Traumatic Injury.
    Watt J; Crilly R
    Calcif Tissue Int; 2017 Apr; 100(4):412-419. PubMed ID: 28213865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.
    Eastell R; Black DM; Boonen S; Adami S; Felsenberg D; Lippuner K; Cummings SR; Delmas PD; Palermo L; Mesenbrink P; Cauley JA;
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3215-25. PubMed ID: 19567517
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program.
    Leslie WD; Aubry-Rozier B; Lix LM; Morin SN; Majumdar SR; Hans D
    Bone; 2014 Oct; 67():10-4. PubMed ID: 24998455
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Femoral neck morphology differentiates femoral neck from vertebral or hip osteoporotic fracture].
    Malavolta N; Frigato M; Mulè R; Ripamonti C
    Reumatismo; 2003; 55(2):93-7. PubMed ID: 12874642
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proton pump inhibitor use is associated with hip fracture development: a nationwide population-based cohort study.
    Min YW; Lee YC; Kim K; Ryu S; Hong KS; Jeon HH; Kim YS; Park JH; Son HJ; Rhee PL
    Korean J Intern Med; 2020 Sep; 35(5):1084-1093. PubMed ID: 31671930
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis.
    Okubo N; Matsui S; Matsumoto T; Sugimoto T; Hosoi T; Osakabe T; Watanabe K; Takami H; Shiraki M; Nakamura T
    Calcif Tissue Int; 2020 Dec; 107(6):559-566. PubMed ID: 32839843
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.
    Rathbun AM; Magaziner J; Shardell MD; Yerges-Armstrong LM; Orwig D; Hicks GE; Hochberg MC
    Osteoporos Int; 2018 Feb; 29(2):365-373. PubMed ID: 29063216
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma.
    Dam TT; Harrison S; Fink HA; Ramsdell J; Barrett-Connor E;
    Osteoporos Int; 2010 Aug; 21(8):1341-9. PubMed ID: 19816753
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
    J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.